{"id":"https://openalex.org/W7204554489","doi":"https://doi.org/10.1007/s13555-026-01876-x","title":"Correction: Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)","display_name":"Correction: Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)","publication_year":2026,"publication_date":"2026-08-28","ids":{"openalex":"https://openalex.org/W7204554489","doi":"https://doi.org/10.1007/s13555-026-01876-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/42663863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13650085"},"language":"en","primary_location":{"id":"doi:10.1007/s13555-026-01876-x","doi":"https://doi.org/10.1007/s13555-026-01876-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01876-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01876-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"erratum","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01876-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024365532","display_name":"Emma Guttman\u2010Yassky","orcid":"https://orcid.org/0000-0002-9363-324X","observed_orcids":["https://orcid.org/0000-0002-9363-324X"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emma Guttman-Yassky","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1047, New York, NY, USA. emma.guttman@mountsinai.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1047, New York, NY, USA. emma.guttman@mountsinai.org","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077872633","display_name":"Alan David Irvine","orcid":"https://orcid.org/0000-0002-9048-2044","observed_orcids":["https://orcid.org/0000-0002-9048-2044"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Alan D. Irvine","raw_affiliation_strings":["Clinical Medicine, Trinity College Dublin, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Medicine, Trinity College Dublin, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006526834","display_name":"Melinda Gooderham","orcid":"https://orcid.org/0000-0001-8926-0113","observed_orcids":["https://orcid.org/0000-0001-8926-0113"]},"institutions":[{"id":"https://openalex.org/I4210087212","display_name":"SKiN Health","ror":"https://ror.org/005wzfh51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210087212"]},{"id":"https://openalex.org/I4210122653","display_name":"Probity Medical Research","ror":"https://ror.org/0222df516","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210122653"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Melinda Gooderham","raw_affiliation_strings":["SKiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough, ON, Canada","institution_ids":["https://openalex.org/I4210087212","https://openalex.org/I4210122653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087084947","display_name":"Stephan Weidinger","orcid":"https://orcid.org/0000-0003-3944-252X","observed_orcids":["https://orcid.org/0000-0003-3944-252X"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Weidinger","raw_affiliation_strings":["Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019091788","display_name":"Lynda J. Spelman","orcid":"https://orcid.org/0000-0002-7330-4713","observed_orcids":["https://orcid.org/0000-0002-7330-4713"]},"institutions":[{"id":"https://openalex.org/I4210147790","display_name":"Veracity Clinical Research","ror":"https://ror.org/04eba0590","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210147790"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Lynda Spelman","raw_affiliation_strings":["Veracity Clinical Research, Woolloongabba, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veracity Clinical Research, Woolloongabba, QLD, Australia","institution_ids":["https://openalex.org/I4210147790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011739266","display_name":"Jonathan I. Silverberg","orcid":"https://orcid.org/0000-0003-3686-7805","observed_orcids":["https://orcid.org/0000-0003-3686-7805"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan I. Silverberg","raw_affiliation_strings":["George Washington University School of Medicine and Health Sciences, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Washington University School of Medicine and Health Sciences, Washington, DC, USA","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130789174","display_name":"Heidi Crane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Crane","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003050074","display_name":"Hany Elmaraghy","orcid":"https://orcid.org/0000-0003-3552-9345","observed_orcids":["https://orcid.org/0000-0003-3552-9345"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hany ElMaraghy","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093252455","display_name":"Louise Ann DeLuca-Carter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louise DeLuca-Carter","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013627472","display_name":"Maria Lucia Buziqui Piruzeli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Lucia Buziqui Piruzeli","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089246132","display_name":"Georgia Martimianaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Georgia Martimianaki","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081642726","display_name":"Evangeline J. Pierce","orcid":"https://orcid.org/0000-0002-8287-2835","observed_orcids":["https://orcid.org/0000-0002-8287-2835"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evangeline Pierce","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092216025","display_name":"Helena Agell","orcid":"https://orcid.org/0009-0005-8742-8062","observed_orcids":["https://orcid.org/0009-0005-8742-8062"]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Helena Agell","raw_affiliation_strings":["Almirall S.A, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall S.A, Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085831636","display_name":"Diamant Tha\u00e7i","orcid":"https://orcid.org/0000-0001-8513-550X","observed_orcids":["https://orcid.org/0000-0001-8513-550X"]},"institutions":[{"id":"https://openalex.org/I9341345","display_name":"University of L\u00fcbeck","ror":"https://ror.org/00t3r8h32","country_code":"DE","type":"education","lineage":["https://openalex.org/I9341345"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Diamant Tha\u00e7i","raw_affiliation_strings":["Institute and Comprehensive Center for Inflammatory Medicine at the University of L\u00fcbeck, L\u00fcbeck, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute and Comprehensive Center for Inflammatory Medicine at the University of L\u00fcbeck, L\u00fcbeck, Germany","institution_ids":["https://openalex.org/I9341345"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5024365532"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"10","first_page":"5263","last_page":"5264"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lebrikizumab","display_name":"lebrikizumab","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/moderate-to-severe-atopic-dermatitis","display_name":"moderate-to-severe atopic dermatitis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.5630000233650208},{"id":"https://openalex.org/keywords/missing-data-handling","display_name":"missing data handling","score":0.7839999794960022},{"id":"https://openalex.org/keywords/multiple-imputation","display_name":"multiple imputation","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7542999982833862},{"id":"https://openalex.org/C2778029271","wikidata":"https://www.wikidata.org/wiki/Q5421931","display_name":"Extension (predicate logic)","level":2,"score":0.48969998955726624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31360000371932983},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.30970001220703125},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2799000144004822},{"id":"https://openalex.org/C2780791683","wikidata":"https://www.wikidata.org/wiki/Q846785","display_name":"Action (physics)","level":2,"score":0.2732999920845032},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2612000107765198},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.23880000412464142},{"id":"https://openalex.org/C25343380","wikidata":"https://www.wikidata.org/wiki/Q277521","display_name":"Relation (database)","level":2,"score":0.23579999804496765},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2184000015258789}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13555-026-01876-x","doi":"https://doi.org/10.1007/s13555-026-01876-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01876-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01876-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},{"id":"pmid:42663863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42663863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and therapy","raw_type":"Published Erratum"},{"id":"pmh:oai:pubmedcentral.nih.gov:13650085","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13650085/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatol Ther (Heidelb)","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:66d9572a9355443d88b0e4ab0ce8de2a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/66d9572a9355443d88b0e4ab0ce8de2a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dermatology and Therapy, Vol 16, Iss 10, Pp 5263-5264 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s13555-026-01876-x","doi":"https://doi.org/10.1007/s13555-026-01876-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13555-026-01876-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13555-026-01876-x.pdf","source":{"id":"https://openalex.org/S4210222097","display_name":"Dermatology and Therapy","issn_l":"2190-9172","issn":["2190-9172","2193-8210"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204554489.pdf","grobid_xml":"https://content.openalex.org/works/W7204554489.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7165114866","https://openalex.org/W4406295719","https://openalex.org/W4391610049","https://openalex.org/W4411539937","https://openalex.org/W4416140380","https://openalex.org/W4388415135","https://openalex.org/W7214065758","https://openalex.org/W7167471865","https://openalex.org/W4361263483","https://openalex.org/W7214179090"],"abstract_inverted_index":{"In":[0],"the":[1,17,56,89],"sentence":[2],"beginning":[3],"'Efficacy":[4],"outcomes":[5],"for":[6,32,65],"participants":[7],"entering":[8],"ADjoin":[9,47,80],"from\u2026\u2026.'":[10],"in":[11],"this":[12,43,76],"article":[13],"under":[14],"\"Statistical":[15],"Analyses\",":[16],"line":[18],"starting":[19],"with":[20],"\"Participants":[21,61],"who":[22,62],"received":[23],"systemic":[24],"or":[25,29],"topical":[26],"rescue":[27],"medication":[28],"discontinued":[30,63],"treatment":[31,64],"any":[33,66],"other":[34,67],"reasons":[35,68],"had":[36,69],"values":[37,70],"set":[38,71],"to":[39,42,46,54,72,75,79,87],"missing":[40,57,73,90],"subsequent":[41,74],"time":[44,77],"through":[45,78],"week":[48,81],"100":[49,82],"and":[50,83],"MI":[51,84],"was":[52,85],"used":[53,86],"handle":[55,88],"data.\"should":[58],"have":[59],"read":[60],"data.\"":[91]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-29T00:00:00"}